The Changing Epidemiology of Clostridium Difficile Infections

Overview

Journal Clin Microbiol Rev

Publisher American Society for Microbiology

Specialty Microbiology

Date 2010 Jul 9

PMID 20610822

Citations 333

Authors

J Freeman

M P Bauer

S D Baines

J Corver

W N Fawley

B Goorhuis

E J Kuijper

M H Wilcox

Affiliations

Soon will be listed here.

Abstract

The epidemiology of Clostridium difficile infection (CDI) has changed dramatically during this millennium. Infection rates have increased markedly in most countries with detailed surveillance data. There have been clear changes in the clinical presentation, response to treatment, and outcome of CDI. These changes have been driven to a major degree by the emergence and epidemic spread of a novel strain, known as PCR ribotype 027 (sometimes referred to as BI/NAP1/027). We review the evidence for the changing epidemiology, clinical virulence and outcome of treatment of CDI, and the similarities and differences between data from various countries and continents. Community-acquired CDI has also emerged, although the evidence for this as a distinct new entity is less clear. There are new data on the etiology of and potential risk factors for CDI; controversial issues include specific antimicrobial agents, gastric acid suppressants, potential animal and food sources of C. difficile, and the effect of the use of alcohol-based hand hygiene agents.

Citing Articles

Attributable Costs of Infections in Korea.

Myung R, Lee E, Kim J, Kim J, Pai H J Korean Med Sci. 2025; 40(4):e22.

PMID: 39901525 PMC: 11790400. DOI: 10.3346/jkms.2025.40.e22.

Whole-Genome Sequencing-Based Characterization of Infection Cases at the University Hospital Centre Zagreb.

Siroglavic M, Higgins P, Kanizaj L, Ferencak I, Juric D, Augustin G Microorganisms. 2025; 12(12.

PMID: 39770637 PMC: 11676685. DOI: 10.3390/microorganisms12122434.

Clostridioides difficile infections caused by hypervirulent strains: a single-centre real-life study.

Tiecco G, De Francesco M, Lenzi A, Pellizzeri S, Rossini F, Sollima A Eur J Clin Microbiol Infect Dis. 2024; 44(1):99-107.

PMID: 39527170 DOI: 10.1007/s10096-024-04982-w.

Unveiling the impact of antibiotic stress on biofilm formation and expression of toxin-antitoxin system genes in Clostridium difficile clinical isolates.

Cheraghi N, Khoshnood S, Sadeghifard N, Khodaei N, Asadollahi P, Bastaminejad S Mol Biol Rep. 2024; 51(1):1060.

PMID: 39419903 DOI: 10.1007/s11033-024-09993-6.

Positive Intervention of Distinct Peptides in Clostridioides difficile Infection in a Mouse Model.

Li Y, Wang Z, Bai L, Li Y, Jiang Y, Xu T Commun Biol. 2024; 7(1):1172.

PMID: 39294333 PMC: 11410834. DOI: 10.1038/s42003-024-06850-x.

References

Pear S, Williamson T, Bettin K, Gerding D, Galgiani J . Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med. 1994; 120(4):272-7. DOI: 10.7326/0003-4819-120-4-199402150-00003. View

Joseph R, Demeyer D, Vanrenterghem D, Van Den Berg R, Kuijper E, Delmee M . First isolation of Clostridium difficile PCR ribotype 027, toxinotype III in Belgium. Euro Surveill. 2006; 10(10):E051020.4. DOI: 10.2807/esw.10.42.02815-en. View

McNulty C, Logan M, Donald I, Ennis D, Taylor D, Baldwin R . Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother. 1998; 40(5):707-11. DOI: 10.1093/jac/40.5.707. View

Wilcox M, Mooney L, Bendall R, Settle C, Fawley W . A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008; 62(2):388-96. DOI: 10.1093/jac/dkn163. View

Geric B, Carman R, Rupnik M, Genheimer C, Sambol S, Lyerly D . Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis. 2006; 193(8):1143-50. DOI: 10.1086/501368. View

Dubberke E, Butler A, Hota B, Khan Y, Mangino J, Mayer J . Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol. 2009; 30(6):518-25. PMC: 4156290. DOI: 10.1086/597380. View

Paltansing S, van den Berg R, Guseinova R, Visser C, van der Vorm E, Kuijper E . Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect. 2007; 13(11):1058-64. DOI: 10.1111/j.1469-0691.2007.01793.x. View

Dial S, Kezouh A, Dascal A, Barkun A, Suissa S . Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008; 179(8):767-72. PMC: 2553880. DOI: 10.1503/cmaj.071812. View

Brown E, Talbot G, Axelrod P, Provencher M, Hoegg C . Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol. 1990; 11(6):283-90. DOI: 10.1086/646173. View

10.

Nasereddin L, Bakri F, Shehabi A . Clostridium difficile infections among Jordanian adult hospitalized patients. Am J Infect Control. 2009; 37(10):864-6. DOI: 10.1016/j.ajic.2009.05.001. View

11.

Biller P, Shank B, Lind L, Brennan M, Tkatch L, Killgore G . Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol. 2007; 28(2):198-201. DOI: 10.1086/511789. View

12.

Goorhuis A, Bakker D, Corver J, Debast S, Harmanus C, Notermans D . Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008; 47(9):1162-70. DOI: 10.1086/592257. View

13.

Kallen A, Thompson A, Ristaino P, Chapman L, Nicholson A, Sim B . Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol. 2009; 30(3):264-72. DOI: 10.1086/595694. View

14.

Valiquette L, Cossette B, Garant M, Diab H, Pepin J . Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007; 45 Suppl 2:S112-21. DOI: 10.1086/519258. View

15.

Baines S, OConnor R, Freeman J, Fawley W, Harmanus C, Mastrantonio P . Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother. 2008; 62(5):1046-52. DOI: 10.1093/jac/dkn313. View

16.

Rupnik M . Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease?. Clin Microbiol Infect. 2007; 13(5):457-9. DOI: 10.1111/j.1469-0691.2007.01687.x. View

17.

Oughton M, Loo V, Dendukuri N, Fenn S, Libman M . Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol. 2009; 30(10):939-44. DOI: 10.1086/605322. View

18.

Wistrom J, Norrby S, Myhre E, Eriksson S, Granstrom G, Lagergren L . Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother. 2001; 47(1):43-50. DOI: 10.1093/jac/47.1.43. View

19.

Arroyo L, Kruth S, Willey B, Staempfli H, Low D, Weese J . PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. J Med Microbiol. 2005; 54(Pt 2):163-166. DOI: 10.1099/jmm.0.45805-0. View

20.

Balassiano I, Miranda K, Boente R, Pauer H, Oliveira I, Santos-Filho J . Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil. Anaerobe. 2009; 15(3):61-4. DOI: 10.1016/j.anaerobe.2008.12.007. View